Hypoxia pretreatment of bone marrow mesenchymal stem cells facilitates angiogenesis by improving the function of endothelial cells in diabetic rats with lower ischemia.
about
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem CellsThe challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapyShort-term hypoxic preconditioning promotes prevascularization in 3D bioprinted bone constructs with stromal vascular fraction derived cells.Remote Ischemic Postconditioning Ameliorates the Mesenchymal Stem Cells Engraftment in Reperfused Myocardium.Macro- and microvascular endothelial dysfunction in diabetes.Extracellular vesicles of ETV2 transfected fibroblasts stimulate endothelial cells and improve neovascularization in a murine model of hindlimb ischemia.Umbilical Cord-Derived Mesenchymal Stem Cells Relieve Hindlimb Ischemia through Enhancing Angiogenesis in Tree Shrews.The Immunomodulatory Effects of Mesenchymal Stem Cell Polarization within the Tumor Microenvironment Niche.Development and optimization of a differentiated airway epithelial cell model of the bovine respiratory tract.Preconditioning influences mesenchymal stem cell properties in vitro and in vivo.Hypoxic Preconditioning Augments the Therapeutic Efficacy of Bone Marrow Stromal Cells in a Rat Ischemic Stroke Model.Bibliometric analysis of global scientific activity on umbilical cord mesenchymal stem cells: a swiftly expanding and shifting focus.CoCl2 Administration to Vascular MSC Cultures as an In Vitro Hypoxic System to Study Stem Cell Survival and Angiogenesis.Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia.Dual IFN-γ/hypoxia priming enhances immunosuppression of mesenchymal stromal cells through regulatory proteins and metabolic mechanisms
P2860
Q26752205-BFD2976A-7A17-4C48-AB01-FDEF6C5081FCQ26775933-E0FBEAD3-FB1B-42DE-B666-095F4EDB4D1DQ33802573-78C85FC6-8101-4572-B37A-1D8E79DDFA9EQ35892642-FDBDEAC4-B716-4242-B05C-6BE655367168Q39065434-19A08E85-26BD-439D-A0E2-83FBAFBE9F6DQ40217744-C0B4DF51-B7B3-4081-8D3B-717878AD630AQ41070279-839C6588-F16B-4951-B1F1-7013CCC1407BQ45913373-AF65B85E-B437-4058-8A92-83B31FD2F2ECQ47552764-38B3B379-9797-4257-AB78-FC9DBE471017Q47697669-196A8D1E-646B-4544-B7B8-3AC777896284Q48218622-A65D1732-5073-45A0-899D-2F63AFF1B0AAQ49491394-086AC420-2394-45D9-9DCB-ED4AA810D7F5Q51534542-2A0431F7-3507-4059-896E-9013E1E10F08Q51608718-096CD5BE-8F19-4D8D-81C7-4A8FBCE92F13Q58575926-0E115360-DF02-414D-A5B4-0D604A9ADC62
P2860
Hypoxia pretreatment of bone marrow mesenchymal stem cells facilitates angiogenesis by improving the function of endothelial cells in diabetic rats with lower ischemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hypoxia pretreatment of bone m ...... etic rats with lower ischemia.
@ast
Hypoxia pretreatment of bone m ...... etic rats with lower ischemia.
@en
type
label
Hypoxia pretreatment of bone m ...... etic rats with lower ischemia.
@ast
Hypoxia pretreatment of bone m ...... etic rats with lower ischemia.
@en
prefLabel
Hypoxia pretreatment of bone m ...... etic rats with lower ischemia.
@ast
Hypoxia pretreatment of bone m ...... etic rats with lower ischemia.
@en
P2093
P2860
P1433
P1476
Hypoxia pretreatment of bone m ...... etic rats with lower ischemia.
@en
P2093
Chuan Tong
Dongdong Ti
Haojie Hao
Hong Huang
Huiling Liu
Jiejie Liu
Liang Dong
Weidong Han
P2860
P304
P356
10.1371/JOURNAL.PONE.0126715
P407
P577
2015-05-21T00:00:00Z